Banner - NPPA Connect

Opinion|Videos|September 28, 2023

Deciding on Treatment for a Patient With GPP

Author(s)Raj Chovatiya, MD, PhD, MSCI, Boni Elewski, MD

Raj Chovatiya, MD, PHD, and Boni Elewski, MD, discuss long-term treatment selection for a patient whose GPP flare cleared with 1 infusion of spesolimab.

Episodes in this series

EP. 1 CASE 1 Presentation: 60-year-old African American Woman With GPP

EP. 1 CASE 1 Presentation: 60-year-old African American Woman With GPP

EP. 2 Utility of Spesolimab in the Management of GPP

EP. 2 Utility of Spesolimab in the Management of GPP

EP. 3 Expert Perspectives on Access and Administration of Spesolimab

EP. 3 Expert Perspectives on Access and Administration of Spesolimab

EP. 4 Benefits of Multidisciplinary Care in the Management of GPP

EP. 4 Benefits of Multidisciplinary Care in the Management of GPP

EP. 5 Importance of Determining GPP Event Trigger

EP. 5 Importance of Determining GPP Event Trigger

EP. 6 Delving Into Treatment Options for Patients With Chronic GPP

EP. 6 Delving Into Treatment Options for Patients With Chronic GPP

EP. 7 Case 2 Presentation: 58-Year-Old Woman With GPP

EP. 7 Case 2 Presentation: 58-Year-Old Woman With GPP

EP. 8 Differential Diagnosis of GPP

EP. 8 Differential Diagnosis of GPP

EP. 9 Individualizing Therapy in GPP

EP. 9 Individualizing Therapy in GPP

EP. 10 CASE 1 Presentation: 61-Year-Old Female With GPP

EP. 10 CASE 1 Presentation: 61-Year-Old Female With GPP

EP. 11 Challenges in Diagnosing GPP

EP. 11 Challenges in Diagnosing GPP

EP. 12 Treatment Selection in GPP

EP. 12 Treatment Selection in GPP

EP. 13 CASE 2 Presentation: 60-Year-Old Woman With A Long History of GPP

EP. 13 CASE 2 Presentation: 60-Year-Old Woman With A Long History of GPP

EP. 14 Deciding on Treatment for a Patient With GPP

EP. 14 Deciding on Treatment for a Patient With GPP

EP. 15 Use of Combination Therapy in GPP

EP. 15 Use of Combination Therapy in GPP

EP. 16 Resources for Patients With GPP

EP. 16 Resources for Patients With GPP

EP. 17 The Many Considerations of Managing Generalized Pustular Psoriasis

EP. 17 The Many Considerations of Managing Generalized Pustular Psoriasis

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Don't Be Rash: Recognizing Pediatric Psoriasis and Its Arthritis Risk

ByAndrew C. Krakowski, MD,Lisa Swanson, MD, FAAD,Kaitlyn Bader, Assistant Managing Editor

August 31st 2026

Treating Psoriasis and Alopecia Areata Beyond the Skin: An Integrative Approach

ByPatricia Delgado, DNP, AGPCNP, DCNP, PMHNP,Jennifer Soung, MD,Shannon Heaning, Content Associate

August 29th 2026

National Psoriasis Awareness Month 2026: More Oral Options, Wider Access, and a Systemic Lens

ByMarie Bosslett, Assistant Editor

August 24th 2026

Imsidolimab Receives European Orphan Designation for Generalized Pustular Psoriasis

ByShannon Heaning, Content Associate

August 24th 2026

Oral IL-23 Blocker Icotrokinra Brings Biologic-Like Efficacy to Psoriasis

ByJennifer Soung, MD,Shannon Heaning, Content Associate

August 18th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

10 Skin Cancer Exam Tips

Journal Digest: September 2, 2026

Dermatology Times Conferences & Meetings Calendar: September 2026